Psychedelic Drugs Market - By Source (Syntheti, Natural), By Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Lysergic Acid Diethylamide [LSD], MethylEnedioxyMethamphetamine......), By Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Other), By Route of Administration (Oral, Inhalation, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and others Read more
- Healthcare
- Mar 2025
- 188
- PDF, Excel, PPT
Market Insights & Analysis: Global Psychedelic Drugs Market (2025-30):
The Global Psychedelic Drugs Market size was valued at around USD 1.92 billion in 2024 and is projected to reach USD 3.8 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 12% during the forecast period, i.e., 2025-30. Increasing awareness about mental health and government Initiatives raising the demand for psychedelic drugs. As per the WHO (World Health Organization), the Global Mental Health, and World Federation for Mental Health, have increased their attention towards mental health and its awareness among consumers worldwide. For instance, the National Alliance of Mental Illness NAMI in 2022, revealed that every year, about 21% of adults in the U.S. are affected by some or other mental health issue and less than half of this population seek professional guidance. Many of them are not aware of the various treatment options.
| Report Coverage | Details |
|---|---|
| Historical Years | 2020-23 |
|
Base Years
|
2024
|
|
Forecast Years
|
2025-30
|
| Market Value in 2024 | USD 1.92 Billion |
| Market Value in 2030 | USD 3.8 Billion |
| CAGR (2025-30) | 12% |
| Leading Region | North America |
| Top Key Players | Jazz Pharmaceuticals, Inc. (U.S.), Janssen Pharmaceuticals, Inc. (U.S.) Hikma Pharmaceuticals PLC (U.K.), Compass, Pfizer Inc., Avadel, AbbVie Inc., Celon Pharma, GH Research, Entheon Biomedical Corp., PharmaTher Holdings Ltd., Usona Institute, Cybin Corp., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, Numinus Wellness Inc., and others |
| Key Report Highlights |
|
*Boost strategic growth with in-depth market analysis - Get a free sample preview today!
Further, government initiatives, alliances, and awareness programs associated with mental health are anticipated to boost market growth over the forecast period. For instance, the Mental Health Foundation has set and hosted Mental Health Awareness Week for the last 22 years, during which the event has grown to become one of the biggest weeks across the UK and globally. Government programs, healthcare coalitions, and public awareness efforts have been important in removing mental health issues and alternative therapy options. For instance, the U.S. National Institute of Drug Abuse developed two drugs as medicine, psychedelic and dissociative drugs. Their development and approval are speeded up due to more awareness among consumers regarding mental health. Research institutions and pharmaceutical companies invest huge sums in clinical trials to ascertain efficacy and safety. Public awareness campaigns and de-stigmatization of mental health issues further support market growth, with patients and healthcare providers considering new solutions like psychedelics.
- Market Segmentation
- Introduction
- Market Definition
- Research Process
- Assumptions
- Executive Summary
- Global Psychedelic Drugs Market Trends & Developments
- Global Psychedelic Drugs Market dynamics
- Drivers
- Challenges
- Global Psychedelic Drugs Market Regulations, Policies & Standards
- Global Psychedelic Drugs Market Hotspot & Opportunities
- Global Psychedelic Drugs Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Size & Analysis
- By Source
- Synthetic -Market Size & Forecast 2020-2030 USD Million
- Natural- Market Size & Forecast 2020-2030, USD Million
- By Drugs
- Gamma-Hydroxybutyric Acid-Market Size & Forecast 2020-2030, USD Million
- Ketamine-Market Size & Forecast 2020-2030, USD Million
- Psilocybin-Market Size & Forecast 2020-2030, USD Million
- Lysergic Acid Diethylamide (LSD)-Market Size & Forecast 2020-2030, USD Million
- MethylEnedioxyMethamphetamine-Market Size & Forecast 2020-2030, USD Million
- By Application
- Narcolepsy
-Market Size & Forecast 2020-2030, USD Million - Treatment Resistant Depression-Market Size & Forecast 2020-2030, USD Million
- Major Depressive Disorder-Market Size & Forecast 2020-2030, USD Million
- Opiate Addiction-Market Size & Forecast 2020-2030, USD Million
- Post-Traumatic Stress Disorder-Market Size & Forecast 2020-2030, USD Million
- Other-Market Size & Forecast 2020-2030, USD Million
- Narcolepsy
- By Route of Administration
- Oral
- Inhalation
-Market Size & Forecast 2020-2030, USD Million - Injectable-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
- By Company
- Competition Characteristics
- Market Share and Analysis
- By Source
- Market Size & Analysis
- North America Psychedelic Drugs Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- By Country
- The US
- Canada
- Mexico
- The U.S. Psychedelic Drugs MarketOutlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Canada Psychedelic Drugs MarketOutlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Mexico Psychedelic Drugs MarketOutlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Market Size & Analysis
- South America Psychedelic Drugs MarketOutlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- By Country
- Brazil
- Argentina
- Rest of South America
- Brazil Psychedelic Drugs Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Argentina Psychedelic Drugs Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Europe Psychedelic Drugs MarketOutlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- By Country
- Germany
- The UK
- France
- Italy
- Spain
- Scandinavia
- Netherlands
- Rest of Europe
- Germany Psychedelic Drugs MarketOutlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- The UK Psychedelic Drugs MarketOutlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- France Psychedelic Drugs Market Outlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Italy Psychedelic Drugs Market Outlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Spain Psychedelic Drugs Market Outlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Market Size & Analysis
- The Middle East & Africa Psychedelic Drugs Market Outlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- By Country
- Saudi Arabia
- The UAE
- South Africa
- Rest of Middle East & Africa
- Saudi Arabia Psychedelic Drugs MarketOutlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- The UAE Psychedelic Drugs Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- South Africa Psychedelic Drugs Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Asia-Pacific Psychedelic Drugs Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- China Psychedelic Drugs Market Outlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Japan Psychedelic Drugs MarketOutlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- India Psychedelic Drugs MarketOutlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- South Korea Psychedelic Drugs Market Outlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Australia Psychedelic Drugs Market Outlook, 2020-2030
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Source- Market Size & Forecast 2020-2030, USD Million
- By Drugs- Market Size & Forecast 2020-2030, USD Million
- By Application-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- Market Size & Analysis
- Global Psychedelic Drugs Market Key Strategic Imperatives for Success & Growth
- Company Profile
- Jazz Pharmaceuticals, Inc. (U.S.)
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Janssen Pharmaceuticals, Inc. (U.S.)
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Hikma Pharmaceuticals PLC (U.K.)
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Compass
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Pfizer Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Avadel
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- AbbVie Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Celon Pharma
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- GH Research
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Entheon Biomedical Corp
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- PharmaTher Holdings Ltd.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Usona Institute
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Cybin Corp.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- F. Hoffmann-La Roche Ltd
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- AstraZeneca PLC
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Numinus Wellness Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Others
- Jazz Pharmaceuticals, Inc. (U.S.)
- Company Profile
- Disclaimer
MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:
1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.
2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.
3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.
4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making
FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT